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LETTERS
cattle (2,8). Taken together, the preva-
lence of EHEC serotype O145:H– in
cats, humans, and cattle might indi-
cate that the girl was probably more
likely the infection source for the cat
than vice versa. Third, a cycle of
mutual infection and reinfection
between the girl and her pet cat cannot
be ruled out. Although the excretion
rate for EHEC changes over time and
EHEC can therefore remain undetect-
ed in stool samples while still present
within the patient, the child tested
EHEC negative for a short period.
Despite all the precautions taken, the
girl may have been reinfected by the
cat.
This case illustrates several issues:
1) domestic animals such as cats (3),
dogs (3,4), and rabbits (9) may serve
as reservoirs for EHEC, irrespective
of whether they are the primary or
secondary source for these bacteria;
2) domestic cats as carriers may
excrete EHEC for a prolonged period;
3) autovaccination may be effective
for treating EHEC-infected animals;
and 4) fondness for pets may be prob-
lematic: although EHEC O145:H– is
among the 4 most often isolated
EHEC serotypes associated with
severe colitis or life-threatening
hemolytic uremic syndrome (10), the
girl’s parents, after weighing the
infectious risks against the psycholog-
ical benefits for both their daughter
and her feline companion, decided not
to send the cat to an animal shelter
until its EHEC infection disappeared.
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Misdiagnosing
Melioidosis
To the Editor: Melioidosis is
endemic in southern and Southeast
Asia and northern Australia. Although
relatively few indigenous cases are
recognized in the Indian subcontinent,
a substantial proportion of cases
imported into the United Kingdom
originate there, probably reflecting
patterns of immigration and travel,
and underdiagnosis within the Indian
subcontinent (1–3).
A 33-year-old woman spent 3
months in India. Shortly after arriving
there, fever, myalgia, rigors, pharyn-
gitis, and tender cervical lym-
phadenopathy developed. After she
received antimicrobial agents, her
symptoms initially improved, but in
September 2005, 1 week after return-
ing to the United Kingdom, she visit-
ed her general practitioner with recur-
rent fever and increasingly painful
cervical lymphadenopathy. She was
given a course of oral co-amoxiclav
625 mg 3× daily. However, the fol-
lowing week she visited the emer-
gency department of her local hospital
with left-sided suppurative cervical
lymphadenitis. Pus aspirated from the
lymph node grew an aminoglycoside-
resistant “pseudomonad” identified as
Pseudomonas fluorescens (API20NE
profile 1056554), assumed to be a
contaminant. She was discharged
home to complete a further 10-day
course of co-amoxiclav.
One month later, the patient again
went to the emergency department,
this time with a submental abscess.
An otolaryngology consultation was
sought, and the abscess was incised
and drained. Although tuberculosis
was suspected, no acid-fast bacilli
were identified, and cultures were
negative for mycobacteria; histologic
examination showed noncaseating
granulomata. Culture of fluid from the
submental collection again yielded an
aminoglycoside-resistant pseudomon-
ad, however. At this point misidentifi-
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cation was suspected, and the isolate,
which had a characteristic colony
form on Ashdown’s Medium, micro-
scopic appearance (Figure, panel A),
API20NE profile (1556574), and fatty
acid profile, was identified as
Burkholderia pseudomallei, the etio-
logic agent of melioidosis.
The patient had no relevant past
medical history. Before immigrating
to the United Kingdom 3 years earlier,
she had lived in Tanjore, a rice-farm-
ing area of Tamil Nadu. She had
stayed with family there during her
recent trip, which coincided with the
monsoon season, but she denied rural
travel, fresh water contact, or skin
abrasions. On examination, she was
obese with acanthosis nigricans and
tender cervical lymphadenopathy.
Blood tests showed a mild microcyto-
sis, low ferritin level, and erythrocyte
sedimentation rate 40 mm/h; serum
biochemistry and levels of C-reactive
protein, fasting glucose, and hemo-
globin by electrophoresis were nor-
mal. Two blood cultures were nega-
tive. Results of chest and abdominal
imaging were normal. The patient was
treated with intravenous ceftazidime
for 10 days and oral co-trimoxazole
for 4 months. She remains well.
B. pseudomallei serologic tests,
performed subsequently, showed neg-
ative results by ELISA against the
standard laboratory strain (204).
However, when the assay was repeat-
ed using the patient’s own isolate, the
result was positive (immunoglobulin
G titer 4,000). Comparison of
lipopolysaccharide (LPS) antigens
from the 2 strains by sodium dodecyl
sulfate–polyacrylamide gel elec-
trophoresis and immunoblotting
showed that they differed in O-repeat-
ing units (Figure, panel B).
B. pseudomallei is an aerobic,
gram-negative, environmental sapro-
phyte ubiquitous in soil and surface
water (e.g., paddy fields) in disease-
endemic areas. Acquisition may occur
through skin abrasions, aspiration of
fresh water, inhalation, and possibly
ingestion and may occasionally occur
in the laboratory. An association
between severe respiratory melioido-
sis and heavy monsoonal rains sug-
gests that inhalation has previously
been underrecognized as a route of
infection (4); this is the likely mode in
this case.
Many infections are initially sub-
clinical but may result in latency and
delayed manifestations, even after
several decades. Clinical signs and
symptoms include septicemia, cavi-
tating pneumonia, bone and soft tissue
infections, disseminated abscesses,
mycotic aneurysms, lymphadenitis,
and childhood parotitis. Most patients
have an underlying predisposition to
infection, especially diabetes, renal
disease, alcoholism, and thalassemia,
but in the largest Indian case series
50% patients had no traditional risk
factors, as with our patient (5). B.
pseudomallei is a category B potential
bioterrorism agent.
Limited awareness of the disease,
confusion with other conditions such
as tuberculosis, and laboratory con-
straints all probably contribute to
underdiagnosis of melioidosis in
many areas (6). However, accurate
diagnosis is important because sep-
ticemic melioidosis may be rapidly
fatal, B. pseudomallei is intrinsically
resistant to many antimicrobial
agents, and prolonged treatment is
usually required to minimize relapse.
Diagnosis is usually by culture from
sterile sites. Laboratory misidentifica-
tion is not uncommon and occurred in
this case because the diagnosis was
not considered. Isolation of aminogly-
coside-resistant pseudomonads in
patients from disease-endemic areas
should always prompt consideration
of melioidosis and accurate identifica-
tion. PCR is an emerging diagnostic
tool not yet extensively validated (7).
The role of serology in diagnosis is
limited by high background seroposi-
tivity rates in disease-endemic areas.
No standardized serologic test is inter-
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Figure. A) Gram stain of pus from the patient’s submental collection, showing the char-
acteristic safety-pin pattern (arrows) of bipolar staining. B) Sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis of lipopolysaccharide (LPS) antigens from the patient and
Burkholderia pseudomallei reference strain (204), showing different O-repeating units
(bracket). A control isolate of Pseudomonas aeruginosa LPS (PA01) is shown for com-
parison.
A B
LETTERS
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 2, February 2007 351
nationally agreed upon. This case
illustrates another potential pitfall in
melioidosis serodiagnosis. Most iso-
lates express a conserved LPS antigen,
which allows use of a single reference
strain for determination of anti-LPS
antibodies (8). However, because
some strains express different LPS
antigens, serologic tests must be per-
formed with the patient’s own strain.
This case illustrates potential pit-
falls in diagnosing melioidosis, which
requires clinical and laboratory aware-
ness and knowledge of its geographic
distribution. LPS-based serologic
assays should use a range of isolates
representative of known LPS types.
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Subclinical
Plasmodium 
falciparum
Infection and HIV-1
Viral Load 
To the Editor: Studies indicate
that Plasmodium falciparum infection
increases HIV replication in adults
(1,2). Although malaria-related illness
and death are more common in chil-
dren, and HIV-1 generally progresses
faster in children than in adults (3,4),
to our knowledge the effect of inter-
mittent malaria on HIV-1 viral load
has not been directly explored in chil-
dren. To investigate this issue, we
monitored HIV-positive infants from
a 1996–2001 birth cohort study in
Kisumu, Kenya, a P. falciparum–
holoendemic area.
Study design and methods have
been described elsewhere (5,6).
Twenty-four children that were peri-
natally infected with HIV were
included in this substudy. During
monthly visits during the child’s first
2 years of life, malaria and HIV inci-
dence were recorded (5,6). Both chil-
dren with malaria-positive blood
smears and those with fever but no
smear result available were treated
with sulfadoxine-pyrimethamine
according to national guidelines. At
the time of this substudy, none of the
study participants were taking anti-
retroviral drugs.
HIV and malaria diagnoses were
determined by using standard meth-
ods (5–7). To reduce the chance of
including infants infected through
breast-feeding, perinatal infection was
defined as >2 consecutive HIV-posi-
tive tests, with the first positive PCR
result by 4 months of age (7). The so-
called baseline viral load was the pre-
malaria value measured 1 month
before the first observation in the
analysis. To be included in the analy-
sis, follow-up visits had to have data
available on the current and previous
months’ viral load and malaria status
and occur at roughly monthly inter-
vals at >4 months of age.
Malaria parasites were found at 53
of 146 visits in the month before viral
load measurement, although at 89%
of visits in which children were
malaria-positive, the children’s sam-
ples had <1,000 parasites/µL, and in
only 13% of visits in which children
had parasitemia did they also have
fever (8). Median number of observa-
tions per child was 7 (range 2–18). No
significant demographic or clinical
differences were found between HIV-
positive children in this substudy and
those enrolled in the full cohort (data
not shown).
Clinical and demographic vari-
ables were evaluated in univariate
repeated measures analysis to deter-
mine associations with log-trans-
formed HIV-1 viral load. Age and
